About this episode
In this episode, our guest, (Founder & CEO of Sapient) - Dr. Jain is a physician-scientist with more than 20 years of expertise in physiology, biomedicine, engineering, computational biology, and mass spectrometry-based metabolomics. He formed and managed Jain Laboratory at the University of California San Diego, where he guided a multi-disciplinary research team to develop next-generation rapid liquid chromatography-mass spectrometry (rLC-MS) systems to probe the non-genetic landscape of disease across large-scale human studies.Talking Points:3 reasons genetics alone are not enough to personalize medicine.New methods for biomarker discovery, validation, & translation for clinical impact.The pitfalls of drug development and how they should be improved.Guest - Dr. Mohit Jainwww.sapient.bio TwitterLinkedInYouTubeWebHost - Hillary Blackburn, PharmD, MBAwww.hillaryblackburn.com https://www.linkedin.com/in/hillary-blackburn-67a92421/ @talktoyourpharmacist for Instagram and Facebook@HillBlackburn Twitter/X
? Support this podcast on Patreon ?
